Why Foot Temperature Matters in Diabetes
In people with diabetes and peripheral neuropathy, the loss of protective sensation means that the earliest warning signs of tissue breakdown are no longer painful. Long before a callus splits or a blister opens, the underlying tissue is inflamed from repetitive mechanical stress, and that inflammation produces a measurable signal: a rise in skin temperature at the affected site compared with the same location on the opposite foot. Capturing that signal at home, before the skin breaks, has become one of the most actively studied prevention strategies in diabetic foot care.
This matters because ulcer recurrence is common — roughly 40% within one year of healing and approaching 65% at five years. Detecting pre-ulcerative inflammation early opens a window in which simple changes, most importantly reducing weight-bearing activity, can interrupt the path to ulceration.
The Evidence Base
The 2.2°C threshold
The clinical signal that drives temperature-based prevention is a side-to-side asymmetry. When a corresponding region on one foot is more than 2.2°C (4°F) warmer than the same region on the contralateral foot on two consecutive days, the warmer area is treated as a “hotspot” representing inflammation. This threshold was established in the foundational randomized work of Lavery and colleagues and has been carried forward into modern devices and current guidelines (Lavery et al., Diabetes Care, 2007).
Randomized and meta-analytic data
A 2022 meta-analysis pooled five RCTs comprising 772 high-risk participants and reported a relative risk of foot ulcer of 0.51 (95% CI, 0.31–0.84) in those using temperature monitoring, with the certainty of evidence rated low because of heterogeneity in designs and devices (Golledge et al., Diabetes/Metabolism Research and Reviews, 2022). The largest contemporary trial, DIATEMP, randomized 304 high-risk patients across multiple centres; after 18 months, ulcer recurrence occurred in 36% of the monitoring group versus 47% of usual-care participants (van Netten et al., 2023). A subsequent cost-effectiveness analysis concluded that home monitoring was at best equivalent to usual care once self-monitoring burden was factored in (Bus et al., Diabetes/Metabolism Research and Reviews, 2024).
What the IWGDF recommends
The 2023 IWGDF Prevention Guideline recommends that clinicians instruct patients at IWGDF risk 2 or 3 to self-monitor foot skin temperatures once daily to identify early signs of inflammation. When a hotspot exceeding 2.2°C is detected on two consecutive days, patients are instructed to reduce ambulatory activity and contact a trained clinician (Bus et al., 2024).
From Handheld Thermometers to Smart Wearables
The original trials used inexpensive handheld infrared thermometers, but the technology has expanded substantially. A 2024 systematic review of smart wearable devices in diabetic foot care identified dozens of distinct platforms, including instrumented socks, insoles with embedded thermistors, and pressure-sensing mats placed at the bedside, many of which upload data automatically to a smartphone or clinician dashboard (Najafi et al., Journal of NeuroEngineering and Rehabilitation, 2024). An earlier study of an in-home smart mat reported prediction of 97% of non-acute plantar ulcers with an average lead time of approximately five weeks, applying the same 2.2°C rule (Frykberg et al., Diabetes Care, 2017). Whether these automated platforms outperform a basic handheld thermometer in routine practice remains an open question.
Practical and Behavioural Considerations
Across every trial, one variable has emerged as decisive: adherence. Monitoring works only when performed daily and only when the patient responds to a hotspot by reducing activity. DIATEMP reported 86% of participants using the device at least three times weekly, yet effectiveness fell when readings were ignored. Other issues include consistent positioning, comparison of anatomically matched sites, and the recognition that not all asymmetries are pre-ulcerative — early Charcot neuro-osteoarthropathy, soft-tissue infection, and recent injury also produce hotspots and require different responses.
Clinical Takeaways
Home foot temperature monitoring is now a guideline-endorsed prevention strategy for people with diabetes at moderate to high ulcer risk. It is low-cost in its simplest form, supported by randomized evidence showing roughly a halving of ulcer risk in pooled analyses, and most effective when patients measure daily and respond to hotspots by reducing activity. Smart wearables are extending manual thermometry into continuous, automated monitoring, though their superiority over basic handheld devices is not yet established. As with most prevention tools in diabetic foot care, the technology is only as good as the behavioural change it supports.
References
- Bus SA, Sacco ICN, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3651.
- Golledge J, Fernando ME, Alahakoon C, et al. Efficacy of at home monitoring of foot temperature for risk reduction of diabetes-related foot ulcer: A meta-analysis. Diabetes/Metabolism Research and Reviews. 2022;38(6):e3549.
- van Netten JJ, Sacco ICN, Lavery LA, et al. Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP). BMJ Open Diabetes Research & Care. 2023.
- Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool. Diabetes Care. 2007;30(1):14–20.
- Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers. Diabetes Care. 2017;40(7):973–980.
- Najafi B, Reeves ND, Armstrong DG, et al. Diabetic foot prevention, assessment, and management using innovative smart wearable technology: a systematic review. Journal of NeuroEngineering and Rehabilitation. 2024.
Comments
